Invenire Partners, LP Optimize Rx Corp Transaction History
Invenire Partners, LP
- $65.3 Million
- Q3 2022
A detailed history of Invenire Partners, LP transactions in Optimize Rx Corp stock. As of the latest transaction made, Invenire Partners, LP holds 105,000 shares of OPRX stock, worth $518,700. This represents 100.0% of its overall portfolio holdings.
Number of Shares
105,000Holding current value
$518,700% of portfolio
100.0%Shares
1 transactions
Others Institutions Holding OPRX
# of Institutions
90Shares Held
12.2MCall Options Held
800Put Options Held
18.1K-
First Light Asset Management, LLC Edina, MN1.81MShares$8.95 Million1.22% of portfolio
-
Black Rock Inc. New York, NY1.18MShares$5.81 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY1.07MShares$5.29 Million1.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA953KShares$4.71 Million0.0% of portfolio
-
Blair William & CO Chicago, IL677KShares$3.34 Million0.02% of portfolio
About OptimizeRx Corp
- Ticker OPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 18,023,100
- Market Cap $89M
- Description
- OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...